Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Update in minimal invasive therapy in benign prostatic hyperplasia.

Authors:
P Van Hest F D'Ancona

Minerva Urol Nefrol 2009 Sep;61(3):257-68

Department of Urology, Canisius Wilhemina Hospital, Nijmegen, The Netherlands.

Last decade several new treatment modalities for minimal invasive therapy of benign prostatic hyperplasia have been developed, both ablative and non-ablative. In this review the authors describe the different techniques and clinical studies of bipolar transurethral resection of the prostate (TURP), transurethral resection in saline (TURis), the different laser therapies for the prostate, transurethral microwave thermotherapy (TUMT), high intensity focused ultrasound (HIFU), transurethral needle ablation (TUNA), hot water induced thermotherapy (WIT), prostatic stents, intraprostatic ethanol injections and botulinum toxin A injections. The different bipolar systems and photoselective vaporisation might replace the ''gold standard'', monopolar TURP, in the near future. The holmium laser enucleation of the prostate is also a real challenger of the ''gold standard'', but the technique is difficult to learn. The TUMT definitively found its place as alternative to TURP, especially because it can be performed in an outpatient setting without the need of anaesthesia. Therefore it is also suitable in patients at high risk. The long-term data on TUNA and HIFU is disappointing and therefore these treatment modalities did not stand the test of time. WIT seemed to be a promising therapy, but durability is questionable. Intraprostatic ethanol injections are safe and effective in small series, but larger series are needed to confirm its efficacy. Intraprostatic botulinum toxin A injections are the first treatment of BPH to target both the increase in smooth muscle tone (dynamic component) and the excessive growth (static component) of BPH. This approach of BPH is very promising but more studies with long-term follow up are needed.

Download full-text PDF

 Source
September 2009

Publication Analysis

Top Keywords

intraprostatic ethanol
8
botulinum toxin
8
treatment modalities
8
transurethral resection
8
prostatic hyperplasia
8
toxin injections
8
''gold standard''
8
benign prostatic
8
therapy benign
8
invasive therapy
8
ethanol injections
8
minimal invasive
8
tumt definitively
4
definitively place
4
place alternative
4
alternative turp
4
turp performed
4
learn tumt
4
performed outpatient
4
suitable patients
4

Keyword Occurance

Similar Publications

[Intravesical foreign body secondary to intraprostatic ethanol injection.]

Authors:
Alessandri Rafael Espinoza Wendy Arenilla Jasson Lavi Germán Cruz Antonio León

Arch Esp Urol 2019 Nov;72(9):968-971

Servicio de Urología. Hospital Universitario de Caracas. Venezuela.

Objective: This study aims to describe the presence of bladder foreign body as a rare complication following intraprostatic ethanol injection.

Case Reports:  A 71-year-old man and a 70-year-old male with bladder catheter probe due to obstructive benign prostatic enlargement underwent ethanol injection via transrectal echography.

Results: The first patient presented a urinary infection with acute urinary retention one year after the procedure. Read More

View Article and Full-Text PDF
November 2019
Similar Publications

Intraprostatic ethanol injection as an alternative therapy in patients with benign prostatic hyperplasia.

Authors:
A R Espinoza

Actas Urol Esp (Engl Ed) 2019 Apr 1;43(3):158-164. Epub 2018 Dec 1.

Departamento de Urología, Hospital Universitario de Caracas, Universidad Central de Venezuela, Caracas, Venezuela. Electronic address:

Introduction: Benign prostatic hyperplasia is a high prevalence worldwide pathology. Amongst its therapeutic options, there are minimally invasive techniques that use locally injected substances (such as ethanol), which produce a chemoablation of this organ.

Objective: The present work aims to evaluate the efficacy of intraprostatic ethanol injection in the treatment of benign prostatic hyperplasia. Read More

View Article and Full-Text PDF
April 2019
Similar Publications

Intraprostatic injections for lower urinary tract symptoms/benign prostatic enlargement treatment.

Authors:
Riccardo Lombardo Karl-Erik Andersson Andrea Tubaro Cosimo De Nunzio

Minerva Urol Nefrol 2018 Dec 3;70(6):570-578. Epub 2018 Oct 3.

Department of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy.

Introduction: Endoscopic surgical treatment represents the gold standard in patients with lower urinary tract symptoms (LUTS) when medical treatment fails. In the past years there has been a growing interest in intraprostatic injections which represent a minimally invasive alternative for those patients not suitable for surgery. Aim of our study is to systematically review all the available data on intraprostatic injections for the treatment of LUTS patients with benign prostatic enlargement (BPE). Read More

View Article and Full-Text PDF
December 2018
Similar Publications

Update on minimally invasive surgery and benign prostatic hyperplasia.

Authors:
Amanda S J Chung Henry H Woo

Asian J Urol 2018 Jan 9;5(1):22-27. Epub 2017 Jun 9.

Sydney Adventist Hospital Clinical School, University of Sydney, Sydney, NSW, Australia.

Transurethral resection of the prostate (TURP) became the gold standard surgical treatment for benign prostatic obstruction without undergoing randomized controlled trials against the predecessor standard in open suprapubic prostatectomy. TURP has historically been associated with significant morbidity and this has fuelled the development of minimally invasive surgical treatment options. Improvements in perioperative morbidity for TURP has been creating an ever increasing standard that must be met by any new technologies that are to be compared to this gold standard. Read More

View Article and Full-Text PDF
January 2018
Similar Publications

Stereological comparison of intraprostatic injection of alcohol and bleomycin with finasteride gavages in rats.

Authors:
Ali Eslahi Ali Noorafshan Ali-Reza Safarpour Masood Sepehrimanesh Ali Ariafara Elham Nadimi

Cent European J Urol 2017 Jun 13;70(2):163-169. Epub 2017 Apr 13.

Gastrointestinal and Liver Disease Research Center, Guilan University of Medical Sciences, Rasht, Iran.

Introduction: Resection of the prostate is one of the standard surgical treatments for symptomatic Benign Prostatic Hyperplasia (BPH). To evaluate minimally invasive treatments, intraprostatic injections of ethanol and bleomycin were compared with oral finasteride administration in rats with BPH.

Material And Methods: The rats were divided into six groups. Read More

View Article and Full-Text PDF
June 2017
Similar Publications
}